Studying drug effects on human muscles just got easier thanks to a new "muscle-on-a-chip," developed by a team of researchers from Penn's School of Engineering and Applied Science and Inha University in Incheon, Korea.
Jul 8, 2021
0
24
In the fight against viruses, antibodies have the potential to either block infection or enable infection and make the disease worse, leading to concern about their use as a therapy for COVID-19.
Jun 21, 2021
0
27
Tissue-engineering scaffolds built around ultrashort peptides provide a new platform for studying bone regeneration in the lab.
Jun 17, 2021
0
1
White adipose tissue (WAT), or white fat, plays a fundamental role in the development of cerebral malaria in mouse models and humans, according to a new study led by Harvard T.H. Chan School of Public Health scientists in ...
Apr 20, 2021
0
32
Age-related macular degeneration (AMD), which leads to a loss of central vision, is the most frequent cause of blindness in adults 50 years of age or older, affecting an estimated 196 million people worldwide. There is no ...
Mar 29, 2021
0
77
Every 12 minutes, someone in the United States dies of pancreatic cancer, which is often diagnosed late, spreads rapidly and has a five-year survival rate at approximately 10 percent. Treatment may involve radiation, surgery ...
Mar 9, 2021
0
99
In a mouse study, Australian researchers have mapped out what happens behind the scenes in fat tissue during intermittent fasting, showing that it triggers a cascade of dramatic changes, depending on the type of fat deposits ...
Mar 2, 2021
0
154
Monash University researchers have uncovered the barrier to β-cell (beta cell) regeneration that could pave the way for improved treatments for diabetes and diseases that involve organ and tissue damage.
Feb 12, 2021
0
17
A method that instructs immune system cells to help repair damaged tissues in the intestine has been developed by researchers at KU Leuven and Seoul National University. This opens the way for more effective treatment of ...
Feb 8, 2021
0
63
A large team of researchers affiliated with a host of institutions in the U.S., France and Spain has found that the drug plitidepsin worked better at treating COVID-19 than did remdesivir in a lab setting. In their paper ...
